This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
News Briefs: Week of March 14-18
By News Staff
MedPAC Recommends Physician Payment Increase, Assails SGR Formula
MedPAC's payment recommendation takes several factors into account, including the level of beneficiary access to Medicare physician services, physician acceptance of Medicare patients and a "modest expected growth in physician and other health professionals' costs."
The report found that beneficiary access to Medicare physicians and other health professionals is good overall. But a small share of the Medicare population continues to report problems finding a new primary care physician -- an essential component to a well-functioning delivery system, the report notes.
The report also criticizes the SGR, saying that it "neither rewards individual providers who restrain unnecessary volume growth nor penalizes those who contribute most to inappropriate volume increases." Indeed, says the report, a largely untold cost of the SGR is "mounting frustration in the provider community stemming from the uncertainty of future Medicare payments."
Pfizer Subsidiary Recalls Extended-release Opioid Analgesic
According to a statement on the Embeda website, the manufacturer said that the issue is not likely to cause adverse events, and patients can continue to take the pain medication as prescribed. King said patients should not stop taking the medication abruptly but should instead talk to their physician about alternative treatments before completing their current prescription.
King said the medication, a long-acting Schedule II opioid analgesic, likely will be unavailable for several months and added that patients seeking a refund should contact their pharmacy.
The drug was approved by the FDA in 2009 as an abuse-resistant painkiller. However, 13 lots of the medication were recalled in June 2010 after it failed stability testing, and two lots were recalled in December.
GSK Updates Prescribing Information, Patient Guide for Advair Products
The FDA announced last year that manufacturers of long-acting beta agonists, or LABAs, must include new warnings on their package labels. Both Advair products are included in this class.
GSK said it made the following changes to prescribing guidelines for the products:
- Use of an LABA without concomitant use of a long-term asthma control medication, such as an inhaled corticosteroid, is contraindicated in the treatment of asthma;
- LABAs should not be used in patients whose asthma is adequately controlled on low- or medium-dose inhaled corticosteroids;
- LABAs should be used as additional therapy only for patients with asthma who are currently taking, but are not adequately controlled on, a long-term asthma control medication, such as an inhaled corticosteroid;
- After asthma control is achieved and maintained, patients should be assessed at regular intervals, and step-down therapy should begin if it can be accomplished without loss of asthma control. The patient should continue to be treated with a long-term asthma control medication, such as an inhaled corticosteroid.
Merck & Co. Inc. issued updated prescribing information and medication guide for formoterol fumarate inhalation powder, which is marketed as Foradil Aerolizer, last August.
PCPCC Creates New ACO-Focused Center
The new Center for Accountable Care will focus on identifying and making recommendations on regulations and policies to advance the success of ACOs with a strong PCMH foundation. In this capacity, the center will identify and share best practices involved in establishing PCMH-centered ACOs and work to educate stakeholders about the center's policy recommendations.
AAFP Past President Ted Epperly, M.D., of Boise, Idaho, will serve as one of four co-chairs of the PCPCC center. Epperly currently is program director and CEO of the Family Medicine Residency of Idaho and a clinical professor in the family medicine department at the University of Washington School of Medicine in Seattle.
FDA Takes Action Against McNeil
The consent decree also requires McNeil to adhere to a strict timetable to bring facilities in Puerto Rico and Lancaster, Pa., into compliance. McNeil also must hire an independent expert to inspect all three facilities to determine whether violations have been corrected and to certify that proper manufacturing practices are in place.
Manufacturing deficiencies have led McNeil to conduct several recalls in the past two years. The FDA opened a company-wide investigation of McNeil Consumer Healthcare last year.
CDC Revamps Website in Anticipation of National Infant Immunization Week
One of the new tools is a binational immunization resource (2-page PDF; About PDFs) designed to help physicians who provide care to children who received some of their vaccinations in Mexico. The resource has information regarding 17 vaccine-preventable diseases -- including a chart that illustrates the English and Spanish names of the vaccines and the doses and ages recommended in both countries -- to help physicians review a child's Mexican immunization records and determine which vaccinations are needed.
Advance Care Planning Is Focus of Special Day
The NHDD initiative is a collaborative effort involving national, state and community organizations that are committed to ensuring adults with decision-making capacity have the information to communicate and document their health care decisions regarding end-of-life treatment preferences.
The initiative's website offers resources and ideas for participants to engage in outreach activities to bring attention to this issue.
IOM Report Focuses on Healthy People 2020 Priorities
The IOM released the information in a March 15 report. The leading health indicators cited in the report are the following measures of health-related concepts that reflect public health concerns:
- proportion of the population with access to health care;
- proportion of the population engaged in healthy behaviors;
- prevalence and mortality of chronic disease;
- proportion of the population experiencing a healthy physical environment;
- proportion of the population experiencing a healthy social environment;
- proportion of the population that experiences injury;
- proportion of the population experiencing positive mental health;
- proportion of healthy births;
- proportion of the population engaged in responsible sexual behavior;
- proportion of the population engaged in substance abuse;
- proportion of the population using tobacco; and
- proportion of the population receiving quality health care services.
- increase the proportion of people with a primary care provider;
- increase the proportion of people who receive evidence-based clinical preventive services;
- improve health literacy;
- reduce the prevalence of children and adolescents who are considered obese;
- reduce the consumption of calories from solid fats and added sugars in children ages 2 years and younger;
- increase the proportion of adults who meet federal physical activity guidelines;
- reduce tobacco use by adults; and
- reduce the initiation of tobacco use by children, adolescents and young adults.
U.S. Supreme Court Rejects Vaccine Design Defect Claim
In a concurring opinion, Justice Stephen Breyer cited an amici curiae ("friends of the court") brief (37-page PDF; About PDFs) filed by the American Academy of Pediatrics. The AAFP signed on to that brief, which urged the court to confirm that the National Childhood Vaccine Injury Act of 1986 preempts all design defect claims against vaccine manufacturers.